Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG103 in Type 2 Diabetes
NCT05348122Phase 2Unknown
- Sponsor
- CSPC Baike Biopharmaceutical
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of GX-G6 in type 2 diabetes mellitus (T2DM), sponsored by CSPC Baike Biopharmaceutical. Status: unknown.
02
Drugs
GX-G6
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05348122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05348122.